BJL
PTCT icon

Brighton Jones LLC’s PTC Therapeutics PTCT Stock Holding History

Brighton Jones LLC’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Buy
+3,148
New +$227K ﹤0.01% 1131
2025
Q3 		– Sell
-4,628
Closed -$226K – 1053
2025
Q2 		$226K Buy
+4,628
New +$220K 0.01% 832

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Brighton Jones LLC's PTCT Position: Q2 2026 in Review

Brighton Jones LLC opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 3,148 shares worth $257K. The stake represents ﹤0.01% of the portfolio and ranks #1131 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in PTCT as recently as Q2 2025.

Brighton Jones LLC first reported a position in PTCT in Q2 2025 and has held it in 2 quarters since. 383 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Brighton Jones LLC held 3,148 shares of PTC Therapeutics worth $257K as of Q2 2026.
  • PTC Therapeutics was a new Brighton Jones LLC position in Q2 2026.
  • PTC Therapeutics made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1131 holding.
  • Brighton Jones LLC first reported a position in PTC Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • 383 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.